Therapeutics for obesity and obesity-related conditions.
Tanai Therapeutics has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in September 2024.
Tanai Therapeutics's investors include Novo Nordisk, BioGeneration Ventures, V-Bio Ventures, Qbic Fund, VIB.
Tanai Therapeutics is headquartered in Gent, Belgium.
Therapeutics for obesity and obesity-related conditions.
Tanai Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tanai Therapeutics — Funding & Investors." VCBacked, September 19, 2024, https://www.vcbacked.co/company/tanai-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Tanai Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/tanai-therapeutics
{{cite web |title=Tanai Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tanai-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated